676 Chris Moxham: Co-Founder & CEO of Transcripta Bio
On this episode of The Kara Goldin Show, we’re joined by Chris Moxham, CEO of Transcripta Bio, a biotech company revolutionizing drug discovery through the power of AI and transcriptomics. With a unique platform built on a vast perturbation atlas of small molecules, Transcripta is uncovering novel opportunities across a wide range of human diseases—faster and with more precision than traditional methods.In our conversation, Chris shares the story behind Transcripta Bio and how the team is building frontier AI models to predict biological responses from potential drug compounds. We dive into…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.